The renal risks of smoking

Kidney International

Volumn 51, Issue 6, 1997, Pages 1669-1677

  Orth, Stephan R ^a   Ritz, Eberhard ^b   Schrier, Robert W ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; KIDNEY DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING;

EID: 0030979318     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.232     Document Type: Article

References (154)

1. BARTECCHI CE, MACKENZIE TD, SCHRIER RW: The human costs of tobacco use (first of two parts). N Engl J Med 330:907-912, 1994
2. MACKENZIE TD, BARTECCHI CE, SCHRIER RW: The human costs of tobacco use (second of two parts). N Engl J Med 330:975-980, 1994
3. BARTECCHI CE, MACKENZIE TD, SCHRIER RW: The global tobacco epidemic. Sci Am May:44-51, 1995
4. REPORT OF THE SURGEON GENERAL: Cardiovascular Disease. Washington DC, U.S. Department of Health and Human Services Office on Smoking and Health, 1983DHHS (PHS), 84-50204, 1904
5. HOLBROOK JS, GRUNDY SM, HENNEKENS CH, KANNEL WB, STRONG JP: Cigarette smoking and cardiovascular diseases: A statement for health professionals by a task force appointed by the steering committee of the American Heart Association. Circulation 70:1114A-1117A, 1984
6. NEWCOMB PA, CARBONE PP: The health consequences of smoking. Cancer Med Clin N Am 76:305-331, 1992
7. PARKIN DM, PISANI P, LOPEZ AD, MASUYER E: At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 59:494-504, 1994
8. LA VECCHIA C, BOYLE P, FRANCESCHI S, LEVI F, MAISONNEUVE P, NEGRI E, LUCCHINI F, SMANS M: Smoking and cancer with emphasis on Europe. Eur J Cancer 27:94-104, 1991
9. LA VECCHIA C, NEGRI E, D'AVANZO B, FRANCESCHI S: Smoking and renal cell carcinoma. Cancer Res 50:5231-5233, 1990
10. MACLURE M, WILLETT W: A case-control study of diet and risk of renal adenocarcinoma. Epidemiology 1:430-440, 1990
11. MCCREDIE M, STEWART JH: Risk factors for kidney cancer in New South Wales. I. Cigarette smoking. Eur J Cancer 28A:2050-2054, 1992
12. MCLAUGHLIN JK, GAO YT, GAO RN, ZHENG W, JI BT, BLOT WJ, FRAUMENI JF JR: Risk factors for renal cell cancer in Shanghai, China. Int J Cancer 52:562-565, 1992
13. KREIGER N, MARRETT LD, DODDS L, HILDITCH S, DARLINGTON GA: Risk factors for renal cell carcinoma: Results of a population-based case-control study. Cancer Causes Control 4:101-110, 1993
14. MELLEMGAARD A, ENGHOLM G, MCLAUGHLIN JK, OLSEN JH: Risk factors for renal cell carcinoma in Denmark. I. Role of socioeconomic status, tobacco use, beverages, and family history. Cancer Causes Control 5:105-113, 1994
15. SCHLEHOFER B, HEUER C, BLETTNER M, NIEHOFF D, WAHRENDORF J: Occupation, smoking and demographic factors, and renal cell carcinoma in Germany. Int J Epidemiol 24:51-57, 1995
16. MUSCAT JE, HOFFMANN D, WYNDER EL: The epidemiology of renal cell carcinoma. A second look. Cancer 75:2552-2557, 1995
17. MCLAUGHLIN JK, LINDBLAD P, MELLEMGAARD A, MCCREDIE M, MANDEL JS, SCHLEHOFER B, POMMER W, ADAMI HO: International renal-cell cancer study. I. Tobacco use. Int J Cancer 60:194-198, 1995
18. MCLAUGHLIN JK, HRUBEC Z, HEINEMAN EF, BLOT WJ, FRAUMENI JF JR: Renal cancer and cigarette smoking in a 26-year followup of U.S. veterans. Public Health Rep 105:535-537, 1990
19. D'AVANZO B, NEGRI E, LA VECCHIA C, GRAMENZI A, BIANCHI C, FRANCESCHI S, BOYLE P: Cigarette smoking and bladder cancer. Eur J Cancer 26:714-718, 1990
20. SORAHAN T, SOLE G: Coarse fishing and urothelial cancer: A regional case-control study. Br J Cancer 62:138-141, 1990
21. MCLAUGHLIN JK, SILVERMAN DT, HSING AW, ROSS RK, SCHOENBERG JB, YU MC, STEMHAGEN A, LYNCH CF, BLOT WJ, FRAUMENI JF JR: Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 52:254-257, 1992
22. MCCREDIE M: Bladder and kidney cancers. Cancer Surv 19-20:343-368, 1994
23. JARRAR K, JOHANSSON B, BOLM-AUDORFF U, WOITOWITZ H-J, WEIDNER W: Fall-Kontroll-Studie zur Erkennung ausserberuflicher Risikofaktoren für Tumoren der ableitenden Harnwege. Dtsch Med Wschr 121:325-330, 1996
24. SHERMAN CB: The health consequences of cigarette smoking: Pulmonary diseases. Med Clin N Am 76:355-375, 1992
25. MOMMSEN S, AAGAARD J: Tobacco as a risk factor in bladder cancer. Carcinogenesis 4:335-338, 1983
26. KUNZE E, CHANG-CLAUDE J, FRENTZEL-BEYME R: Life style and occupational risk factors for bladder cancer in Germany, a case-control study. Cancer 69:1776-1790, 1992
27. JUNGE B: Jahrbuch Sucht '96: Tabak, in Hamm: Deutsche Hauptstelle gegen die Suchtgefahren, 1996, pp 69-83
28. FOWLER JS, VOLKOW ND, WANG G-J, PAPPAS N, LOGAN J, MACGREGOR R, ALLEXOFF D, SHEA C, SCHLYER D, WOLF AP, WARNER D, ZEZULKOVA I, CLLENTO R: Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733-736, 1996
29. Cigarette smoking among adults-United States, 1991. MMWR Morb Mortal Wkly Rep 42:230-233, 1993
30. VOLHARD F, FAHR T: Die Brightsche Nierenkrankheit, in Klinik, Pathologie und Atlas, Berlin, Heidelberg, New York, Springer, 1914, pp 225-239
31. RITZ E, FLISER D: Clinical relevance of albuminuria in hypertensive patients. Clin Invest 70:S114-S119, 1992
32. RITZ E, NOWICKI M, FLISER D, HÖRNER D, KLIMM HP: Proteinuria and hypertension. Kidney Int 46(Suppl 47):S76-S80, 1994
33. LEWIN A, BLAUFOX MD, CASTLE H, ENTWISLE G, LANGFORD H: Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. Arch Intern Med 145:424-427, 1985
34. SAMUELSSON O, WILHELMSEN L, ELMFELDT D, PENNERT K, WEDEL H, WIDSTRAND J, BERGLUND G: Predictors of cardiovascular morbidity in treated hypertension; Results from the primary preventive trial in Göteborg, Sweden. J Hypertens 3:167-176, 1985
35. MIMRAN A, RIBSTEIN J, DUCAILAR G, HALIMI JM: Albuminuria in normals and essential hypertension. J Diabetes Compl 8:150-156, 1994
36. HÖRNER D, FLISER D, KLIMM HP, RITZ E: Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. J Hypertens 14:655-660, 1996
37. DECKERT T, FELDT-RASMUSSEN B, BORCH-JOHNSON K, JENSEN T, KOFOAD-ENAVOLDSEN A: Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219-226, 1989
38. DALES LG, FRIEDMAN GD, SIEGELAUB AB, SELTZER CC, URY HK: Cigarette smoking habits and urine characteristics. Nephron 20:163-170, 1978
39. WHELTON PK, RANDALL B, NEATON J, STAMLER J, BRANCATI FL, KLAG MJ: Cigarette smoking and ESRD incidence in men screened for the MRFIT. (abstract) J Am Soc Nephrol 6:408a, 1995
40. FORD ES, MALARCHER A, HERMAN W, AUBERT R: Smoking and diabetes: Findings from the 1989 National Health Interview Survey. Diabetes Care 17:688-692, 1994
41. MOY CS, LAPORTE RE, DORMAN JS, SONGER TJ, ORCHARD TJ, KULLER LH, BECKER DJ, DRASH AL: Insulin-dependent diabetes mellitus mortality. The risk of cigarette smoking. Circulation 82:37-43, 1990
42. KLEIN R, MOSS SE, KLEIN BEK, DEMETS DL: Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 149:266-272, 1989
43. MANSON JE, COLDITZ GA, STAMPFER MJ, WILLETT WC, KRÓLEWSKI AS, ROSNER B, ARKY RA, SPEIZER FE, HENNEKENS CH: A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 151:1141-1147, 1991
44. MORRISH NJ, STEVENS LK, HEAD J, FULLER JH, JARRETT RJ, KEEN H: A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO multinational study of vascular disease in diabetics) II: Associated risk factors. Diabetologia 33:542-548, 1990
45. ROSENGREN A, WELIN L, TSIPOGIANNI A, WILHELMSEN L: Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: A general poulation study. Br Med J 299:1127-1131, 1989
46. STAMLER J, VACCARO O, NEATON JD, WENTWORTH D: Diabetes, other risk factors, and 12-yr. cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16:434-444, 1993
47. WARRAM JH, LAFFEL LM, GANDA OP, CHRISTLIEB AR: Coronary artery disease is the major determinant of excess mortality in patients with insulin-dependent diabetes mellitus and persistent proteinuria. J Am Soc Nephrol 3(Suppl 4):S104-S110, 1992
48. STEGMAYR BG: A study of patients with diabetes mellitus (type 1) and end-stage renal failure: Tobacco usage may increase risk of nephropathy and death. J Intern Med 228:121-124, 1990
49. STEGSMAYR B, LITHNER F: Tobacco and end stage diabetic nephropathy. Br Med J 295:581-582, 1987
50. PERRY RJ, GRIFFITHS W, DEXTRAZE P, SOLOMON RJ, TREBBIN WM: Elevated nicotine levels in patients undergoing hemodialysis. A role in cardiovascular mortality and morbidity? Am J Med 76:241-246, 1984
51. CHRISTIANSEN JS: Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1:146-149, 1978
52. MÜHLHAUSER I, SAWICKI P, BERGER M: Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia 29:500-502, 1986
53. COUPER JJ, STAPLES AJ, COCCIOLONE R, NAIRN J, BADCOCK N, HENNING P: Relationship of smoking and albuminuria in children with insulin-dependent diabetes. Diabetic Med 11:666-669, 1994
54. TELMER S, CHRISTIANSEN JS, ANDERSEN AR, NERUP J, DECKERT T: Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 215:63-68, 1984
55. ALMDAL T, NÖRGAARD K, FELDT-RASMUSSEN B, DECKERT T: The predictive value of microalbuminuria in IDDM. A five-year follow-up study. Diabetes Care 17:120-125, 1994
56. CHASE HP, GARG SK, MARSHALL G, BERG CL, HARRIS S, JACKSON WE, HAMMAN RE: Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. JAMA 265:614-617, 1991
57. MICROALBUMINURIA COLLABORATIVE STUDY GROUP UNITED KINGDOM: Risk factors for development of microalbuminuria in insulin dependent diabetic patients: A cohort study. Br Med J 306:1235-1239, 1993
58. BIESENBACH G, JANKO O, ZAZGORNIK J: Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrol Dial Transplant 9:1097-1102, 1994
59. SAWICKI PT, DIDJURGEIT U, MÜHLHAUSER I, BENDER R, HEINEMANN L, BERGER M: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 17:126-131, 1994
60. RIMM EB, CHAN J, STAMPFER MJ, COLDITZ GA, WILLETT WC: Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. Br Med J 310:555-559, 1995
61. PERRY IJ, WANNAMETHEE SG, WALKER MK, THOMSON AG, WHINCUP PH, SHAPER AG: Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. Br Med J 310:560-564, 1995
62. OLIVARIUS NDEF, ANDREASEN AH, KEIDING N, MOGENSEN CE: Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark. Diabetologia 36:1007-1016, 1993
63. KELLER CK, BERGIS KH, FLISER D, RITZ E: Renal findings in patients with short term type 2 diabetes. J Am Soc Nephrol (in press)
64. MATTOCK M, BARNES D, VIBERTI GC, KEEN H, FITZGERALD A, BURT D, JACKSON PG: Predictors of the development of microalbuminuria in type 2 diabetic patients. Diabetologia 38(Suppl 1):A63, 1995
65. BRUNO G, CAVALLO-PERIN P, BARGERO G, BORRA M, CALVI V, D'ERRICO N, DEAMBROGIO P, PAGANO G: Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care 19:43-47, 1996
66. CORRADI L, ZOPPI A, TETTAMANTI F, MALAMANI G, LAZZARI P, FOGARI R: Association between smoking and micro-albuminuria in hypertensive patients with type 2 diabetes mellitus. J Hypertens 11(Suppl 5):S190-S191, 1993
67. KLEIN R, KLEIN BEK, MOSS SE: Incidence of gross proteinuria in older-onset diabetes. A population-based perspective. Diabetes 42: 381-389, 1993
68. PAETKAU ME, BOYD TAS, WINSHIP B, GRACE M: Cigarette smoking and diabetic retinopathy. Diabetes 26:46-49, 1977
69. CHEN MS, KAO CS, CHANG CJ, WU TJ, FU CC, CHEN CJ, TAI TY: Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol 114:723-730, 1992
70. KLEIN R, KLEIN BEK, DAVIS MD: Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol 118:228-238, 1983
71. KELLY WF, NICHOLAS J, ADAMS J, MAHMOOD R: Necrobiosis lipoidica diabeticorum: Association with background retinopathy, smoking, and proteinuria. A case controlled study. Diabetic Med 10:725-728, 1993
72. WAEBER B, SCHALLER M-D, NUSSBERGER J, BUSSIEN J-P, HOFBAUER KG, BRUNNER HR: Skin blood flow reduction induced by cigarette smoking: Role of vasopressin. Am J Physiol 247:H895-H901, 1984
73. SAWICKI PT, KAISER S, HEINEMANN L, FRENZEL H, BERGER M: Prevalence of renal artery stenosis in diabetes mellitus-An autopsy study. J Intern Med 229:489-492, 1991
74. APPEL RG, BLEYER AJ, REAVIS S, HANSEN KJ: Renovascular disease in older patients beginning renal replacement therapy. Kidney Int 48:171-176, 1995
75. ZUCCHELLI P, ZUCCALA A: Ischaemic nephropathy, in Oxford Textbook of Clinical Nephrology, edited by CAMERON S, DAVISON AM, GRÜNFELD J-P, KERR D, RITZ E, Oxford, New York, Tokyo, Oxford University Press, 1996
76. CHAPMAN AB, JOHNSON AM, GABOW PA, SCHRIER RW: Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:1349-1354, 1994
77. WARD MM, STUDENSKI S: Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 152:2082-2088, 1992
78. YAQOOB M, BELL GM, PERCY DF, FINN R: Primary glomerulonephritis and hydrocarbon exposure: A case-control study and literature review. Q J Med 83:409-418, 1992
79. HERODY M, BOBRIE G, GOUARIN C, GRÜNFELD JP, NOEL LH: Anti-GBM disease: Predictive value of clinical, histological and serological data. Clin Nephrol 40:249-255, 1993
80. MERKEL F, PULLIG O, MARX M, NETZER KO, WEBER M: Course and prognosis of anti-basement membrane antibody. Nephrol Dial Transplant 9:372-376, 1994
81. WENZLAFF P, AMENDE I: Progression der Koronarsklerose nach Einstellen des Zigarettenrauchens. Z Kardiol 83:703-710, 1994
82. WITTEMAN JCM, GROBBEE DE, VALKENBURG HA, VAN HEMERT AM, STIJNEN T, HOFMAN A: Cigarette smoking and the development and progression of aortic atherosclerosis: A 9-year population-based follow-up study in women. Circulation 88:2156-2162, 1993
83. HIGMAN DJ, STRACHAN AMJ, POWELL JT: Reversibility of smoking-induced endothelial dysfunction. Br J Surg 81:977-978, 1994
84. WANG XL, TAM C, MCCREDIE RM, WILCKEN DEL: Determinants of severity of coronary artery disease in Australian men and women. Circulation 89:1974-1981, 1994
85. WANG XL, SIM AS, BADENHOP RF, MCCREDIE RM, WILCKEN DEL: A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med 2:41-45, 1996
86. PAWLIK WW, JACOBSON ED, BANKS RO: Actions of nicotine on renal function in dogs (42046). Proc Soc Exp Biol Med 178:585-590, 1985
87. EKBERG G, GREFBERG N, LARSSON L-O, VAARA I: Cigarette smoking and glomerular filtration rate in insulin-treated diabetics without manifest nephropathy. J Intern Med 228:211-217, 1990
88. NEURINGER JR, BRENNER BM: Hemodynamic theory of progressive renal disease: A 10-year update in brief review. Am 3 Kidney Dis 22:98-104, 1993
89. HOSTETTER TH: Progression of renal disease and renal hypertrophy. Annu Rev Physiol 57:263-278, 1995
90. BURN JH, TRUELOVE LH, BURN I: The antidiuretic action of nicotine and of smoke. Br Med J 1:403-406, 1945
91. CADNAPAPHORNCHAI P, BOYKIN JL, BERL T, MCDONALD KM, SCHRIER RW: Mechanism of effect of nicotine on renal water excretion. Am J Physiol 227:1216-1220, 1974
92. HUSAIN MK, FRANTZ AG, CIAROCHI F, ROBINSON AG: Nicotine-stimulated release of neurophysin and vasopressin in humans. J Clin Endocrinol Metab 41:1113-1117, 1975
93. ROWE JW, KILGORE A, ROBERTSON GL: Evidence in man that cigarette smoking induces vasopressin release via an airway-specific mechanism. J Clin Endocrinol Metab 51:170-172, 1980
94. BANKIR L, BOUBY N, TRINH-TRANG-TAN MM: Vasopressin-dependent kidney hypertrophy: Role of urinary concentration in protein-induced hypertrophy and in the progression of chronic renal failure. Am J Kidney Dis 17:661-665, 1991
95. BANKIR L, BOUBY N: Vasopressin and urinary concentration: Additional risk factors in the progression of chronic renal failure. Am J Kidney Dis 17(Suppl 1):20-26, 1991
96. BOUBY N, TRINH-TRANG-TAN MM, COUTAUD C, BANKIR L: Vasopressin is involved in renal effects of high-protein diet: Study in homozygous Brattleboro rats. Am J Physiol 260:F96-F100, 1991
97. HULTBERG B, ISAKSSON A, BRATTSTRÖM L, ISRAELSSON B: Elevated urinary excretion of b-hexosaminidase in smokers. Eur J Clin Chem Clin Biochem 30:131-133, 1992
98. BUCHET JP, LAUWERYS R, ROELS H, BERNARD A, BRUAUX P, CLAEYS F, ET AL: Renal effects of cadmium body burden on the general population. Lancet 336:699-702, 1990
99. WONG LTY, SMYTH DD, SITAR DS: Interference with renal organic cation transport by (-)- and (+)-nicotine at concentrations documented in plasma of habitual tobacco smokers. J Pharmacol Exp Ther 261:21-25, 1992
100. GREEN MS, JUCHA E, LUZ Y: Blood pressure in smokers and nonsmokers: Epidemiologic findings. Am Heart J 111:932-940, 1986
101. HESSE E: Ein fluss des Rauchens auf den Kreislauf. Dtsch Arch Klin Med 89:565-575, 1907
102. CRYER PE, HAYMOND MW, SANTIAGO JV, SHAH SD: Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemudynamic and metabolic events. N Engl J Med 295: 573-577, 1976
103. BAER L, RADICHEVICH I: Cigarette smoking in hypertensive patients. Blood pressure and endocrine responses. Am J Med 78:564-568, 1985
104. GROPPELLI A, GIORGI DMA, OMBONI S, PARATI G, MANCHIA G: Persistent blood pressure increase induced by heavy smoking. J Hypertens 10:495-499, 1992
105. MANN SJ, JAMES GD, WANG RS, PICKERING TG: Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case control study. JAMA 265:2226-2228, 1991
106. ARONOW WS, SWANSON AJ: Non-nicotinized cigarettes and angina pectoris. Ann Intern Med 70:1227, 1969
107. ARONOW WS, ROKAW SN: Carboxyhemoglobin caused by smoking nonnicotine cigarettes. Effects in angina pectoris. Circulation 44:782-788, 1971
108. ARONOW WS, DENDINGER J, ROKAW SN: Heart rate and carbon monoxide level after smoking high-, low-, and non-nicotine cigarettes. A study in male patients with angina pectoris. Ann Intern Med 74:697-702, 1971
109. HANSEN KW, PEDERSEN MM, CHRISTIANSEN JS, MOGENSEN CE: Night blood pressure and cigarette smoking: Disparate association in healthy subjects and diabetic patients. Blood Pressure 3:381-388, 1994
110. BARNA I, KEMPLER P, BÜKI B, DE CHATEL R: The influence of chronic smoking on the diurnal rhythm of blood pressure in healthy individuals and in insulin dependent diabetic patients. (abstract) Nephrol Dial Transplant 11:A80, 1996
111. CAMPESE VM, BIGAZZI R: The role of hypertension in the progression of renal diseases. Am J Kidney Dis 17(Suppl 1):43-47, 1991
112. KLAG MJ, WHELTON PK, RANDALL BL, NEATON JD, BRANCATI FL, FORD CE, SHULMAN NB, STAMLER J: Blood pressure and end-stage renal disease in men. N Engl J Med 334:13-18, 1996
113. KLAHR S, LEVEY AS, BECK GJ, CAGGIULA AW, HUNSICKER L, KUSEK JW, STRIKER G, MODIFICATION OF DIET IN RENAL DISEASE (MDRD) STUDY GROUP: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
114. PETERSON JC, ADLER S, BURKART JM, GREENE T, HEBERT LA, HUNSICKER LG, KING AJ, KLAHR S, MASSRY SG, SEIFERT JL, MODIFICATION OF DIET IN RENAL DISEASE (MDRD) STUDY GROUP: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754-762, 1995
115. MASCHIO G, ALBERTI D, JANIN G, LOCATELLI F, MANN JFE, MOTOLESE M, PONTICELLI C, RITZ E, ZUCCHELLI P, ANGIOTENSIN-CONVERTING-ENZYME INHIBITION IN PROGRESSIVE RENAL INSUFFICIENCY STUDY GROUP: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
116. FACCHINI FS, HOLLENBECK CB, JEPPESEN J, CHEN Y-DI, REAVEN GM: Insulin resistance and cigarette smoking. Lancet 339:1128-1130, 1992
117. ELIASSON B, ATTVALL S, TASKINEN M-R, SMITH U: The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb 14:1946-1950, 1994
118. WANG PH, LAU J, CHALMERS TC: Meta-analysis of effects of intensive blood glucose control on late complications of type 1 diabetes. Lancet 341:1306-1309, 1993
119. GODSLAND IF, WYNN V, WALTON C, STEVENSON JC: Insulin resistance and cigarette smoking. Lancet 339:1619-1620, 1992
120. JANZON L, BERNTORP K, JANSSON M, LINDELL, S-E, TRELL E: Glucose tolerance and smoking: A population study of oral and intravenous glucose tolerance tests in middle-aged men. Diabetologia 25:86-88, 1983
121. BLONK MC, JACOBS MAJM, FRIEDBERG CE, NAUTA JJP, TEERLINK T, POPP-SNIJDERS C, HEINE RJ: Determinants of insulin sensitivity and consequences for lipoproteins and blood pressure in subjects with non-insulin-dependent diabetes mellitus. Metabolism 43:501-508, 1994
122. HAWKINS RI: Smoking, platelets and thrombosis. Nature 236:450-452, 1972
123. BLACHE D, BOUTHILLIER D, DAVIGNON J: Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by Aspirin. Atherosclerosis 93:179-188, 1992
124. DAVIS JW, ARNOLD J, WIEGMANN T: Cigarette-smoking affects platelets and endothelium in chronic hemodialysis patients. Nephron 64:359-364, 1993
125. NADLER JL, VELASCO JS, HORTON R: Cigarette smoking inhibits prostacyclin formation. Lancet 4:1248-1250, 1983
126. BARROW SE, WARD PS, SLEIGHTHOLM MA, RITTER JM, DOLLERY CT: Cigarette smoking: Profiles of thromboxane- and prostacyclin-derived products in human urine. Biochim Biophys Acta 993:121-127, 1989
127. UEDELHOFEN WM, RÜTZEL A, MEESE CO, WEBER PC: Smoking alters thromboxane metabolism in man. Biochim Biophys Acta 1081: 197-201, 1991
128. PITTILO RM, BULL HA, GULATI S, ROWLES PM, BLOW CM, MACHIN SJ, WOOLF N: Nicotine and cigarette smoking: Effects on the ultrastructure of aortic endothelium. Int J Exp Pathol 71:573-586, 1990
129. LIN S-J, HONG C-Y, CHANG M-S, CHIANG BN, CHIEN S: Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats. Arterioscler Thromb 12:1305-1312, 1992
130. NORONHA-DUTRA AA, EPPERLEIN MM, WOOLF N: Effect of cigarette smoking on cultured human endothelial cells. Cardiovasc Res 27:774-778, 1993
131. DUPÄA C, COUFFINHAL T, LABAT L, FAWAZ J, MOREAU C, BIETZ I, BONNET J: Monocyte adherence to endothelial cells in patients with atherosclerosis: Relationship with risk factors. Eur J Clin Invest 23:474-479, 1993
132. KALRA VK, YING Y, DEEMER K, NATARAJAN R, NADLER JL, COATES TD: Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 160: 154-162, 1994
133. STROHSCHNEIDER T, OBERHOFF M, HANKE H, HANNEKUM A, KARSCH KR: Effect of chronic nicotine delivery on the proliferation rate of endothelial and smooth muscle cells in experimentally induced vascular wall plaques. Clin Invest 72:908-912, 1994
134. BLANN AD: The acute influence of smoking on the endothelium. Atherosclerosis 96:249-250, 1992
135. BLANN AD, MCCOLLUM CN: Adverse influence of cigarette smoking on the endothelium. Thromb Haemostas 70:707-711, 1993
136. CELERMAJER DS, SORENSEN KE, GEORGAKOPOULOS D, BULL C, THOMAS O, ROBINSON J, DEANFIELD JE: Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88(part 1):2149-2155, 1993
137. CELERMAJER DS, SORENSEN KE, GOOCH VM, SPIEGELHALTER DJ, MILLER OI, SULLIVAN ID, LLOYD JK, DEANFIELD JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115, 1992
138. CELERMAJER DS, ADAMS MR, CLARKSON P, ROBINSON J, MCCREDIE R, DONALD A, DEANFIELD JE: Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 334:150-154, 1996
139. RÅNGEMARK C, WENNMALM Å: Endothelium-dependent and -independent vasodilation and reactive hyperemia in healthy smokers. J Cardiovasc Pharmacol 20(Suppl 12):S198-S201, 1992
140. KIOWSKI W, LINDER L, STOSCHITZKY K, PFISTERER M, BURCKHARDT D, BURKART F, BÜHLER FR: Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 90:27-34, 1994
141. EGASHIRA K, INOU T, HIROOKA Y, YAMADA A, MAKUOKA Y, KAI H, SUGIMACHI M, SUZUKI S, TAKESHITA A: Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 91:29-37, 1993
142. KYRIAKIDES ZS, KREMASTINOS DT, RENTOUKAS E, MAVROGHENI S, KREMASTINOS DI, TOUTOUZAS P: Acute effects of cigarette smoking on left ventricular diastolic function. Eur Heart J 13:743-748, 1992
143. BODMER CW, VALENTINE DT, MASSON EA, SAVAGE MW, LAKE D, WILLIAMS G: Smoking attenuates the vasoconstrictor response to noradrenaline in type 1 diabetic patients and normal subjects: Possible relevance to diabetic nephropathy. Eur J Clin Invest 24:331-336, 1994
144. SOLIMAN DM, TWIGG HL III: Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages. Am J Physiol 263: L471-L478, 1992
145. YAMAGUCHI E, ITOH A, FURUYA K, MIYAMOTO Y, ABE S, KAWAKAMI Y: Release of tumor necrosis factor-a from human alveolar macrophages is decreased in smokers. Chest 103:479-483, 1993
146. SAUTY A, MAUEL J, PHILIPPEAUX M-M, LEUENBERGER P: Cytostatic activity of alveolar macrophages from smokers and nonsmokers: Role of interleukin-1B, interleukin-6, and tumor necrosis factor-α. Am J Respir Cell Mol Biol 11:631-637, 1994
147. HOCKERTZ S, EMMENDÖRFFER A, SCHERER G, RUPPERT T, DAUBE H, TRICKER AR, ADLKOFER F: Acute effects of smoking and high experimental exposure to environmental tobacco smoke (ETS) on the immune system. Cell Biol Taxicol 10:177-190, 1994
148. GOODMAN J: To die by smoke. Whither tobacco? in Tobacco in History. The Culture of Dependence. London and New York, Routledge, 1994, pp 241-245
149. CEDERHOLM J, LIDELL, C, NORDGREN L, WIBELL L: Prevalences of risk factors and angiopathy in diabetic patients in Uppsala. Ups J Med Sci 97:69-77, 1992
150. KOCH M, THOMAS B, TSCHÖPE W, RITZ E: Survival and predictors of death in dialysed diabetic patients. Diabetologia 36:1113-1117, 1993
151. BIESENBACH G, GRAFINGER P, ZAZGORNIK J: Influence of smoking on the survival rate of diabetic patients on hemodialysis. Diabetologia 38(Suppl 1):A209, 1995
152. FLEGAL KM, TROIANO RP, PAMUK ER, KUCZMARSKI RJ, CAMPBELL SM: The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 333:1165-1170, 1995
153. MALARCHER AM, FORD ES, NELSON DE, CHRISMON JH, MOWERY P, MERRITT RK, HERMAN WH: Trends in cigarette smoking and physicians' advice to quit smoking among people in the U.S. Diabetes Care 18:694-697, 1995
154. RITZ E, STEFANSKI A: Diabetic nephropathy in type II diabetes. Am J Kidney Dis 27:167-194, 1996